postherpetic
neuralgia
phn
chronically
painful
condition
complication
shingle
acute
herpes
zoster
recurrence
virus
initially
cause
chickenpox
although
shingle
usually
resolve
within
month
people
continue
feel
pain
phn
long
rash
blister
heal
nerve
damage
neuropathic
pain
caused
shingle
everyone
shingle
develops
phn
although
common
complication
shingle
older
adult
despite
advance
antiviral
therapy
acute
herpes
zoster
recent
introduction
vaccination
varicella
zoster
phn
continues
significant
clinical
problem
patient
developing
persistent
neuropathic
pain
acute
herpes
zoster
reactivation
nature
phn
pain
variable
implies
variety
mechanism
might
operating
variability
led
hypothesis
treatment
plan
could
optimised
individual
patient
basis
individual
pattern
symptom
underlying
mechanism
pain
however
current
evidence
base
therapy
phn
based
clinical
trial
analgesic
examined
phn
single
disease
entity
furthermore
little
evidence
efficacy
drug
specific
set
symptom
simple
way
determine
pain
mechanism
might
operating
individual
patient
month
plo
medicine
andrew
rice
colleague
reassessed
evidence
base
systematic
review
analgesic
therapy
phn
fundamentally
changed
wake
several
major
new
trial
author
searched
literature
trial
phn
retrieved
article
kept
final
analysis
analysis
confirmed
several
previous
research
finding
although
cautioned
study
design
collecting
data
range
trial
several
inherent
pitfall
difficult
directly
compare
treatment
across
different
trial
however
found
evidence
analgesic
efficacy
established
phn
orally
administered
therapy
tricyclic
antidepressant
opioids
gabapentin
tramadol
pregabalin
topically
administered
therapy
lidocaine
capsaicin
associated
analgesic
efficacy
selected
patient
however
appeared
therapy
oral
administration
certain
nmda
receptor
antagonist
codeine
ibuprofen
lorazepam
receptor
agonist
acyclovir
efficacious
phn
altogether
author
conclude
evidence
base
support
use
tricyclic
antidepressant
orally
administered
treatment
phn
reserving
gabapentinoids
use
topical
treatment
lidocaine
capsaicin
considered
treatment
patient
fall
sensitised
nociceptor
opposed
deafferentation
phn
patient
role
intrathecal
steroid
still
clear
one
trial
indicated
intrathecal
steroid
associated
benefit
patient
phn
therapy
might
hazardous
author
researcher
concluded
trial
therapy
needed
author
found
little
evidence
regarding
possible
synergistic
effect
various
treatment
support
refute
concomitant
use
combination
drug
stressed
treatment
plan
must
recognise
importance
biopsychosocial
model
chronic
pain
pharmacologically
based
management
phn
combined
advice
management
psychological
social
aspect
finally
single
pathophysiology
underlies
phn
propose
future
study
use
quantitative
sensory
evaluation
clearly
categorise
subset
participant
better
interpretation
treatment
effect